Echocardiography and Structural Heart Symposium, 43rd Annual - Scorecard - MDSpire

Echocardiography and Structural Heart Symposium, 43rd Annual

As valvular heart disease and structural heart treatments become increasingly integral within cardiology, our symposium focuses on building the fundamental tools of echocardiography.

  • By

  • March 20, 2026

  • 2 min

Share

Clinical Scorecard: Echocardiography and Structural Heart Symposium, 43rd Annual

At a Glance

CategoryDetail
Condition
Key Mechanisms
Target PopulationPatients with valvular heart disease, including those with cancer, atrial fibrillation, hypertrophic cardiomyopathy, and other relevant conditions.
Care Setting

Key Highlights

  • Core echocardiography principles covering cardiac structure and function
  • Discussions on the latest technologies in structural heart disease assessment, including controversies
  • Advanced imaging techniques including 3-D, Strain, CT, and TEE
  • Innovative valve repair approaches such as TAVR and TEER
  • Focus on specific patient populations and treatment controversies

Guideline-Based Recommendations

Diagnosis

    Management

    • Implement advanced treatment approaches for valvular heart disease, including TAVR and TEER.

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Individuals with valvular heart disease

        Tailored treatment strategies based on specific conditions and patient demographics

        Clinical Best Practices

        • Adopt a multidisciplinary approach involving cardiologists, surgeons, and sonographers
        • Stay updated on the latest advancements in echocardiography and structural heart treatments
        • Engage in discussions regarding controversies in diagnosis and treatment, as highlighted in the symposium.

        References

          Original Source(s)

          Echocardiography and Structural Heart Symposium, 43rd Annual

          • by

          • March 20, 2026

          Related Content

          Non-sustained Ventricular Tachycardia in Children and Adult Congenital Heart Disease: Optimal Duration and Clinical Significance

          Enhancing Machine Learning Classifier Efficiency for Heart Disease Prediction Through Bacterial Colony Optimization

          US Heart Health Progress Stalls

          New US cardiovascular statistics document persistent gaps in prevention and treatment across hypertension, diabetes, obesity, and cholesterol management, with marked disparities by age, income, and race.